Cl. Strickland et al., Tricyclic farnesyl protein transferase inhibitors: Crystallographic and calorimetric studies of structure-activity relationships, J MED CHEM, 42(12), 1999, pp. 2125-2135
Crystallographic and thermodynamic studies of farnesyl protein transferase
(FPT) complexed with novel tricyclic inhibitors provide insights into the o
bserved SAR for this unique class of nonpeptidic FPT inhibitors. The crysta
llographic structures reveal a binding pattern conserved across the mono-,
di-, and trihalogen series. In the complexes, the tricycle spans the FPT ac
tive site cavity and interacts with both protein atoms and the isoprenoid p
ortion of bound farnesyl diphosphate. An amide carbonyl, common to the tric
yclic compounds described here, participates in a water-mediated hydrogen b
ond to the protein backbone. Ten high-resolution crystal structures of inhi
bitors complexed with FPT are reported. Included are crystallographic data
for FPT complexed with SCH 66336, a compound currently undergoing clinical
trials as an anticancer agent (SCH 66336, 4-[2-[4-(3,10-dibromo-8-chloro-6,
11-dihydro-5H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinyl]-2-o
xoethyl]-1-piperidinecarboxamide). Thermodynamic binding parameters show fa
vorable enthalpies of complex formation and small net entropic contribution
s as observed for 4-[2-[4-(3,10-dibromo-8-chloro-6, 11-dihydro-5H-benzo[5,6
]-cycloheptal[1,2-b]pyridin-11-ylidene)-1-piperidinyl] -2-oxoethyl]pyridine
N-oxide where Delta H-bind(o) = -12.5 kcal/mol and T Delta S-bind(o) = -1.
5 kcal/mol.